TY - JOUR
T1 - Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients
AU - Gelhorn, Heather L.
AU - Skalicky, Anne M.
AU - Balantac, Zaneta
AU - Eremenco, Sonya
AU - Cimms, Tricia
AU - Halling, Katarina
AU - Hollen, Patricia J.
AU - Gralla, Richard J.
AU - Mahoney, Martin C.
AU - Sexton, Chris
N1 - Funding Information:
The authors thank Katelyn Cutts for her assistance during the study and Fritz Hamme, Janet Pooley, and Amara Tiebout for editorial and production assistance. Lastly, the authors thank the staff at the clinical sites and the patients who participated in this study. Dr. Halling is currently employeed and Ms. Cimms formerly employed by AstraZeneca. Dr. Gelhorn and Ms. Skalicky are current salaried employees, and Ms. Eremenco and Dr. Sexton are former employees of Evidera, a consulting company that has received funding from AZ for conducting the study. Dr. Mahoney’s institution received payment for participating in the research study. The authors have no other relevant affiliations or financial involvement with any organization or entity with financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Funding Information:
Funding Funding for this research and manuscript was provided by AstraZeneca.
Publisher Copyright:
© 2018, Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Purpose: Obtaining qualitative data directly from the patient perspective enhances the content validity of patient-reported outcome (PRO) instruments. The objective of this qualitative study was to evaluate the content validity of the Lung Cancer Symptom Scale for Mesothelioma (LCSS-Meso) and its usability on an electronic device. Methods: A cross-sectional methodological study, using a qualitative approach, was conducted among patients recruited from four clinical sites. The primary target population included patients with pleural mesothelioma; data were also collected from patients with peritoneal mesothelioma on an exploratory basis. Semi-structured interviews were conducted consisting of concept elicitation, cognitive interviewing, and evaluation of electronic patient-reported outcome (ePRO) usability. Results: Participants (n = 21) were interviewed in person (n = 9) or by telephone (n = 12); 71% were male with a mean age of 69 years (SD = 14). The most common signs and symptoms experienced by participants with pleural mesothelioma (n = 18) were shortness of breath, fluid build-up, pain, fatigue, coughing, and appetite loss. The most commonly described symptoms for those with peritoneal mesothelioma (n = 4) were bloating, changes in appetite, fatigue, fluid build-up, shortness of breath, and pain. Participants with pleural mesothelioma commonly described symptoms assessed by the LCSS-Meso in language consistent with the questionnaire and a majority understood and easily completed each of the items. The ePRO version was easy to use, and there was no evidence that the electronic formatting changed the way participants responded to the questions. Conclusions: Results support the content validity of the LCSS-Meso and the usability of the electronic format for use in assessing symptoms among patients with pleural mesothelioma.
AB - Purpose: Obtaining qualitative data directly from the patient perspective enhances the content validity of patient-reported outcome (PRO) instruments. The objective of this qualitative study was to evaluate the content validity of the Lung Cancer Symptom Scale for Mesothelioma (LCSS-Meso) and its usability on an electronic device. Methods: A cross-sectional methodological study, using a qualitative approach, was conducted among patients recruited from four clinical sites. The primary target population included patients with pleural mesothelioma; data were also collected from patients with peritoneal mesothelioma on an exploratory basis. Semi-structured interviews were conducted consisting of concept elicitation, cognitive interviewing, and evaluation of electronic patient-reported outcome (ePRO) usability. Results: Participants (n = 21) were interviewed in person (n = 9) or by telephone (n = 12); 71% were male with a mean age of 69 years (SD = 14). The most common signs and symptoms experienced by participants with pleural mesothelioma (n = 18) were shortness of breath, fluid build-up, pain, fatigue, coughing, and appetite loss. The most commonly described symptoms for those with peritoneal mesothelioma (n = 4) were bloating, changes in appetite, fatigue, fluid build-up, shortness of breath, and pain. Participants with pleural mesothelioma commonly described symptoms assessed by the LCSS-Meso in language consistent with the questionnaire and a majority understood and easily completed each of the items. The ePRO version was easy to use, and there was no evidence that the electronic formatting changed the way participants responded to the questions. Conclusions: Results support the content validity of the LCSS-Meso and the usability of the electronic format for use in assessing symptoms among patients with pleural mesothelioma.
KW - HRQL
KW - Lung Cancer Symptom Scale for Mesothelioma (LCSS-Meso)
KW - Patient-reported outcome
KW - Symptoms
UR - http://www.scopus.com/inward/record.url?scp=85045028270&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045028270&partnerID=8YFLogxK
U2 - 10.1007/s00520-018-4061-0
DO - 10.1007/s00520-018-4061-0
M3 - Article
C2 - 29392480
AN - SCOPUS:85045028270
SN - 0941-4355
VL - 26
SP - 2229
EP - 2238
JO - Supportive Care in Cancer
JF - Supportive Care in Cancer
IS - 7
ER -
